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Summary
Background: Regulation of cell size requires coordination of
growth and proliferation. Conditional loss of cyclin-dependent
kinase 1 in mice permits hepatocyte growth without cell divi-
sion, allowing us to study cell size in vivo using transcriptomics
and metabolomics.
Results: Larger cells displayed increased expression of cyto-
skeletal genes but unexpectedly repressed expression of
many genes involved in mitochondrial functions. This effect
appears to be cell autonomous because cultured Drosophila
cells induced to increase cell size displayed a similar gene-
expression pattern. Larger hepatocytes also displayed a
reduction in the expression of lipogenic transcription factors,
especially sterol-regulatory element binding proteins. Inhibi-
tion of mitochondrial functions and lipid biosynthesis, which
is dependent on mitochondrial metabolism, increased the
cell size with reciprocal effects on cell proliferation in several
cell lines.
Conclusions: We uncover that large cell-size increase is
accompanied by downregulation of mitochondrial gene
expression, similar to that observed in diabetic individuals.
Mitochondrial metabolism and lipid synthesis are used to
couple cell size and cell proliferation. This regulatory mecha-
nismmay provide a possiblemechanism for sensingmetazoan
cell size.Introduction
Cell size can be increased by impeding with cell-cycle pro-
gression, increasing the rate of biosynthesis, or both. In
unicellular organisms, cell size and proliferation are mainly
controlled by nutrient levels, whereas regulation through
growth and mitogenic and survival signals is additionally
important in metazoan cells [1]. Cell size increases with ploidy
in many organisms, although the mechanism behind this is
elusive [2, 3]. Saccharomyces cerevisiae has been the pre-
dominant model used to study cell size [2, 4]. Genes affecting*Correspondence: m.bjorklund@dundee.ac.uk
This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/3.0/).cell size have been identified through loss-of-function studies
in yeast [5, 6] and Drosophila [7, 8], as well as through gene-
expression studies of yeast cell-cycle mutants and strains
with variable ploidy [9–11]. However, in mammals, practically
all insights are derived from cultured cells with a focus in
understanding whether there is an active cell-size control
[12–14]. Mechanisms that affect cell size in vivo have received
less attention, apart from the role of mTOR.
Liver is a homogenous tissue mainly composed of hepato-
cytes. Liver regenerates to its normal size after partial hepa-
tectomy ([PH]; removal of w70% of the liver) through cell
growth and division of the remaining cells. Interestingly,
mouse liver with a cyclin-dependent kinase 1 (Cdk1) liver-
specific knockout (Cdk1Flox/Flox Albumin-Cre, hereafter named
Cdk1Liv2/2) can also regenerate. However, this occurs in the
absence of cell divisions, resulting in enlarged hepatocytes
[15]. Because Cdk1 is essential for cell-cycle progression,
this model separates growth and proliferation effects, allowing
us to analyze how mammalian cells respond to cell-size
changes in vivo. We identify how gene-expression andmetab-
olite levels correlate with cell size and discover that both mito-
chondrial metabolism and lipid biosynthesis are used to
couple cell size and cell proliferation.
Results
Correlation of Gene Expression and Metabolite Levels with
Cell Size In Vivo
Liver samples from control (Cdk1Flox/Flox) and Cdk1Liv2/2 ani-
mals, before and after partial hepatectomy, form a series of
samples with different nuclear sizes (Figure 1A). Hepatocytes
from Cdk1Liv2/2 mice after PH have 2–3 times larger radii
than those from Cdk1Flox/Flox mice ([15]; Figure 1B), with rela-
tively uniform size increase because the variation is similar to
controls (Figures 1A and 1B). We measured gene expression
and relative metabolite levels in these four nearly isogenic
sample types using nuclear radius as a proxy for cell size
[2, 3]. We then correlated all gene expression and metabolite
changes to cell size (Figures 1C and 1D; Figures S1A and
S1B available online; Tables S1 and S2). Gene-expression
data were validated by comparing samples before and after
PH (Figure S1C) and by quantitative RT-PCR (Figures S1D
and S1E). To our knowledge, there are no prior data regarding
global gene expression and metabolic changes related to cell
size from metazoan organisms in vivo.
The metabolomics data contained semiquantitative ion in-
tensities, which potentially account for >2,200 metabolites
based on accurate mass annotation and covering a large frac-
tion of the metabolome (Figure S1F). We observed many
changes related to hepatectomy (Figures S1B and S1G),
including known changes in levels of glycogen, glucose,
taurine, betaine, and creatine [16]. We could also identify
changes related to Cdk1 deletion and cell size (Figure S1B).
By plotting the correlation of the nuclear radius and change
in metabolite and gene-expression levels between the largest
and the smallest cells, we observed that the strongest correla-
tions with cell-size change are usually not associated with the
largest fold changes (Figure S1G; Tables S1 and S2).
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Figure 1. Correlation of Gene-Expression and Metabolite Levels with Cell Size in Mouse Liver
(A) Representative Feulgen-stained histological sections of Cdk1Flox/Flox and Cdk1Liv2/2 liver before and 96 hr after PH. The Cdk1Liv2/2 hepatocytes regen-
erate by growing in size because they are unable to divide, whereas the cell size in Cdk1Flox/Flox liver is not significantly changed. All images were taken with
the same magnification. Scale bar represents 20 mm.
(B) Quantification of the nuclear sizes in liver samples. The data shown indicate mean 6 SD of nuclear radius relative to control Cdk1Flox/Flox before PH
(n = 13–55 cells).
(C) Analysis of gene expression by RNA-seq. Four genes displaying strong correlation with nuclear radius are shown as examples with correlation,
and 690% confidence intervals are shown with solid and dotted line, respectively.
(D) A density plot of gene-expression correlations with nuclear radius for all genes. Median Pearson correlation (0.222) for all genes is indicated with the
dotted line.
See also Figure S1 and Tables S1 and S2.
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599At gene-expression level, the fatty acid transporterCd36dis-
played almost perfect linear correlation (r = 0.968) with nuclear
size (Figure 1C). We also identified genes with strong negative
correlation (for example,Ndufb10 [NADH dehydrogenase sub-
unit, r = 20.947]) (Figure 1C), although these were less abun-
dant (118geneswith correlation <20.8withnuclear size versus
302 genes with correlation > 0.8 with nuclear size). Such a
coordinated global gene expression with cell size is consistent
with yeast data [9, 10]. The distribution pattern of all gene and
metabolite correlations with cell size is in Figures 1D and
S1A. The observed gene-expression pattern could result
from downregulation of a few highly expressed genes. How-
ever, the most abundant genes are on average only slightly
downregulated, and the observed positive correlation is due
to increased expression of many genes with low expression
(Figure S1H). Because many of these are regulatory proteins,
these changes might be necessary to support cell growth.
In contrast to yeast, in which G1 cyclins are repressed with
increased cell size [9], the expression of many cell-cycle genescorrelated positively with nuclear size. Cyclins D1–D3, E1, E2,
A2, B1, and B2 displayed a positive correlation with cell size
(r = 0.344–0.761; Table S1), suggesting that repression of
cyclins is not universally required for cell-size increase.
Mitochondrial and Cytoskeletal Genes Strongly Correlate
with Cell Size
Rather than focusing on individual genes, wewanted to identify
whether expression of genes related to various subcellular
components is coordinated with cell size. Comparison of size
correlation distributions for various subcellular structures
basedongeneontology (GO)classifications revealed twostruc-
tures that deviated from thewhole-cell profile. These structures
were cytoskeleton andmitochondria, correlating positively and
negatively, respectively,with cell size (Figures2A, 2B, andS2A).
Because the cytoskeleton is required to mechanically support
cells and is an integral part of various cellular transport mecha-
nisms, the upregulation of cytoskeleton was not unexpected
and has been observed in yeast [9]. Analysis of protein
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Figure 2. Correlation of Gene Expression with Cell Size for Different Subcellular Components Identifies Downregulation of Mitochondrial Genes
(A)Mouse genes annotated to individual subcellular components using gene ontology (GO) analysis were identified, andmedian correlationwith nuclear size
was calculated. Dotted orange line indicates median cell correlation for all genes included in this analysis. We calculated p values using Kolmogorov-
Smirnov test.
(B) Expression correlations for genes annotated to mitochondria and cytoskeleton. Correlations were binned to obtain scaling profiles (bars) for each sub-
cellular component. For comparison, the whole-cell profile (only genes with annotation in any of the subcellular component analyses, as opposed to all
genes in Figure 1D, orange line) is overlaid on the bar chart. The number of genes in thewhole-cell profile was normalized to the number of genes in individual
subcellular components to simplify comparison.
(C) Connectivity of genes correlating negatively (adjusted p value < 0.05) with cell size, as identified using the STRING database. Groups of functionally in-
teracting genes are indicated with green circles and named. Note that one-carbon metabolism genes, such as adenosylhomocysteinase (Ahcy), are impor-
tant for glutathione synthesis, indicating possible coregulation.
(D) Drosophila genes annotated to individual subcellular components as for liver data. Dotted orange line indicates median of log2 fold change for all genes
included in this analysis.
(E) Histograms of mitochondrial and cytoskeletal gene expression compared to all genes (orange line) in Drosophila Kc167 cells.
See also Figure S2 and Tables S3 and S4.
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600complexes indicated that the Wave2 and Arp2/3 complexes
responsible for actinnucleationwereamong themostpositively
correlating complexes (Figure S2B). The negative correlation
between mitochondrial gene expression and nuclear size was
unexpected because mitochondrial deletion mutants in yeast
display small cell size [5, 6], and mitochondrial content scales
with cell size [17, 18]. The genes annotated in the inner mem-
brane and matrix were the most negatively correlating gene
sets within mitochondria (Figures S2C and S2D).
Next, we analyzed the connectivity of the genes correlating
with cell size by using a protein-association network database.
The positively correlating network contained DNA replication
genes, ribosomal protein-coding genes, Rho GTPase-related
genes, cytoskeleton and cell-adhesion-related genes, E2F-
related, and Hippo pathway genes (Figure S2E), all of which
are likely to be involved in growth. The negatively correlating
network contained a large cluster of mitochondrial genes
and smaller clusters containing cholesterol biosynthesis
genes, apolipoprotein and serine protease inhibitors (serpin),
and genes involved in glutathione, phenylalanine and tyrosine,
and one-carbon metabolism (Figure 2C). These networks had
2.3 and 8.1 times more connections per gene, respectively,
than similarly sized random networks, indicating functional in-
teractions (Figure S2E). Many of these findings were corrobo-
rated by metabolomics data, which showed marked changes
in glutathione, one-carbon, and DNA-replication-relatedmeta-
bolism (Table S3). Because one of the major functions of mito-
chondria is oxidative phosphorylation (OxPhos), we analyzedthe expression of OxPhos genes. These displayed strong
negative correlation with nuclear size (Figure S2F).
The identified gene-expression patterns could potentially be
caused by Cdk1 deletion rather than by change in cell size.
However, genes affected by Cdk1 deletion had very limited
overlap with size-correlating genes. This overlap was only
4% (22 of 526) of positively correlating genes and 6% (36 of
569) of negatively correlating genes (Figure S2G), indicating
that the observed effects are not Cdk1 dependent. Addition-
ally, we used gene-expression data from cultured Drosophila
Kc167 cells. Knockdown of Pop2 deadenylase, which causes
degradation of mRNA polyA tails, increases cell size w20%
without major effects on cell cycle (Figures S2H and S2I).
The CCR4-NOT complex, which contains a Pop2 ortholog,
has one of the strongest cell-size effects in yeast [6]. Analysis
of Drosophila RNA-expression data (Table S4) indicated that
mitochondrial genes were significantly downregulated and
that cytoskeletal genes were upregulated (Figures 2D and
2E). The exception to liver data was that ribosomal gene
expression was repressed, and this may be a feedback mech-
anism related to stabilization ofmRNAs. The similarity of gene-
expression signatures in mouse and Drosophila cells implies
that these gene-expression changes are cell-autonomous
effects related to cell size.
Aerobic Glycolysis Fuels Cell Size Increases
The negative correlation of mitochondrial gene expression
with cell size suggested changes in energy metabolism. We
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601did not observe significant changes in mitochondrial number,
size, or number of cristae, although the mitochondria in larger
cells tended to be smaller and slightly more abundant, with
increased electron density (Figures 3A and S3A). Further
analysis of the gene-expression levels of mitochondrial DNA-
replication machinery (Figure S3B) and mitochondrial DNA
amount relative to genomic DNA (Figure S3C) did not indicate
depletion of mitochondria.
Despite negative correlation, the absolute reduction of
mRNA and protein expression of OxPhos complexes in
Cdk1Liv2/2 post-PH samples compared to Cdk1Flox/Flox pre-
PH samples was onlyw20% (Figure 3B), which could explain
the phenotypic difference of yeast deletion mutants [5, 6].
Metabolomics data indicated no changes in ATP levels but a
reduction in AMP levels, which correlated with cell size (Fig-
ure 3C). Consistently, analysis of the cellular energy sensor
AMP-activated kinase (AMPK) indicated downregulation of
AMPK activity in Cdk1Liv2/2 cells (Figure 3B). Thus, ATP levels
are unlikely to be limiting in larger cells, and the lack of AMPK
activation could provide permissive conditions for the cell-size
increase. We conclude that the observed mitochondrial gene-
expression correlation is due to moderate transcriptional
downregulation.
Compensatory increases in glycolysis could maintain ATP
levels, and we indeed observed upregulation of genes related
to three key regulatory steps (Figure 3D). Hexokinase expres-
sion correlated well with cell size, whereas pyruvate kinase
Pkm2 displayed a mixed hepatectomy and cell-size effect.
Additionally, lactate dehydrogenase (Ldha) correlated posi-
tively and pyruvate dehydrogenase (Pdha) correlated nega-
tively with cell size (Figure 3D). Analysis of the metabolite
levels indicated that, whereas changes in glucose levels in
control and Cdk1Liv2/2 animals were roughly similar, changes
caused by PH in pyruvate levels at the end of the glycolytic
pathway were different (Figure S3D). For a summary of all
glycolysis data, see Figures S3D and S3E.
We did not observe significant changes in tricarboxylic acid
(TCA) cycle metabolites (Figure S3D), although we observed
changes in isocitrate dehydrogenases 1 and 2 (Idh1 and
Idh2) as well as in mitochondrial glutaminase 2 (Gls2) and
glutamate dehydrogenase 1 (Glud1), with concomitant in-
crease in glutamate levels (Figure 3E). The glycolytic inhibi-
tor 2-deoxyglucose (2-DG) and the glutamine antagonist
6-Diazo-5-oxo-L-norleucine (DON) abolished the cell-size in-
crease caused by respiratory inhibitor sodium azide in human
osteosarcoma cell line U2OS (Figure 3F). Altogether, these
data suggest that glycolysis and glutaminolysis are required
to fuel cell growth caused by mitochondrial inhibition (by
sodium azide) in vitro and possibly in vivo.
Interestingly, although metabolic changes in early glycol-
ysis displayed a clear hepatectomy effect, Cdk1Liv2/2 geno-
type and cell size had more effect on metabolite levels at
later stages of glycolysis. For example, we observed that
Cdk1Liv2/2 suppressed the increased pyruvate levels caused
by hepatectomy in control animals (Figures S3D and S3E).
Furthermore, hepatectomized Cdk1Liv2/2 knockout mice dis-
played increased metabolite levels related to serine and
glycerol synthesis. These metabolic changes and the positive
correlation of pyruvate kinase Pkm2 expression with cell size
are consistent with tumor-like metabolic phenotype [19].
Overall, the observed cell-size-related metabolic and gene-
expression changes are conceptually similar to the Warburg
effect, in which mitochondrial activity is reduced relative to
glycolysis.Mitochondria Regulate the Balance between Cell Size and
Cell Proliferation
To investigate this putative functional link between mitochon-
dria and cell size, we screened a set of small molecules,
including compounds that target mitochondria and glycolysis,
glutaminolysis, and the pentose phosphate pathway (PPP).
Mitochondria-targeting inhibitors frequently increased cell
size and reduced cell numbers, with a modest inverse correla-
tion (R2 = 0.27) (Figure 4A). The mitochondria-targeting
compounds included uncoupling agents (FCCP and CCCP),
ionophore (valinomycin), mitochondrial division inhibitor
(Mdivi-1), translation inhibitors (minocycline and thiostrepton),
and drugs with mitochondrial off-targets (tamoxifen).
The reciprocal effects on cell size and proliferation are
illustrated with Mdivi-1, which targets the dynamin-related
protein 1 (Drp1), and sodium azide, an inhibitor of OxPhos
complex IV (Figures 4B, S4A, and S4B). Increases in cell size
were similarly detected by electrical current exclusion method
and by measurement of protein amount per cell, arguing
against osmotic effects (Figures S4C and S4D). In contrast to
mitochondrial inhibitors, phenylbutyrate, which enhances
the metabolic flux from glycolysis to mitochondria, caused
increased proliferation and decreased cell size, although it
slowed down proliferation at high concentrations (Figure 4C).
Most nonmitochondria-targeted chemicals had little effect
on cell size, although they reduced cell number and conse-
quently displayed no correlation with cell size (R2 = 0.07) (Fig-
ure 4A). These data, together with our RNAi screen in
Drosophila [7] and recent yeast data [20], indicate that cell
size is, in most cases, not connected to effects in cell prolifer-
ation (cell cycle) as commonly believed.
Genetic means of targeting mitochondrial functions also
increased cell size. U2OSrho0 cells, which do not contain mito-
chondrial DNA and thus are defective in many mitochondrial
functions, were larger than wild-type cells (Figure S4E). Cell
size was also increased by RNAi of the transcriptional coacti-
vator PGC-1a (Figures 4D and 4E), which has been implicated
as an integrator of metabolism and mitochondrial gene
expression by regulating OxPhos, TCA cycle, and lipid synthe-
sis genes.
Because two OxPhos complex inhibitors, antimycin A and
oligomycin, did not increase cell size (TableS5andFigureS4F),
we examinedwhat othermitochondrial functions could explain
the cell-size phenotype. Mitochondrial metabolism is closely
linked to oxidative phosphorylation and proliferation [19, 21].
A key function of mitochondria is to provide acetyl-coenzyme
A (CoA) for histone acetylation as well as for mevalonate and
cholesterol and fatty acid synthesis (Figure S4G). Mitochon-
drial acetyl-CoA is exported to the cytoplasm as citrate.
Although our metabolomic data cannot distinguish subcellular
pools of metabolites, all enzymes involved in the citrate and
acetyl-CoA transport process correlated negatively with cell
size in our gene-expression data (Figure S4G). Additionally,
RNAi of the mitochondrial citrate transporter SLC25A1 in-
creased the size of U2OS and HeLa cells (Figure S4H).
In yeast, acetylation of histones binding to growth gene loci
is important for promoting transcription and inducing prolifer-
ation [22]. We thus tested whether the cell-size effects in our
models are linked to histone acetylation. Histone acetylation
was reduced in larger Cdk1Liv2/2 cells in vivo (Figure S4I), as
well as in U2OS cells treated with rotenone, an OxPhos com-
plex I inhibitor and a potent cell-size inducer (Figure S4J).
However, although all of the histone acetyltransferase inhibi-
tors that were tested reduced cell proliferation, none of these
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Figure 3. Glycolysis Increases with Cell Size
(A) Representative electron microscopy images of Cdk1Flox/Flox and Cdk1Liv2/2 liver before and after hepatectomy. Arrows and ‘‘M’’ indicate glycogen and
mitochondria, respectively. All scale bars represent 500 nm. For quantification, see Figure S3A.
(B) mRNA expression (red line) and protein levels (blue bars) of selected OxPhos proteins.Western blot shows themeasured OxPhos complex components,
phospho-Thr172-AMPK (pAMPK) levels, and GAPDH (loading control).
(C) Relative ATP and AMP levels in liver samples, as measured by mass spectrometry. Statistical significance was measured by ANOVA.
(D) Proportional expression of key glycolytic genes based on liver RNA-seq data.
(E) Glutamate metabolite levels (orange) and Idh expression levels (blue and gray) correlate with cell size.
(F) Inhibition of glycolysis and glutaminolysis by 2-DG and DON rescue U2OS cell size increase by 1 mM sodium azide (p < 0.001 in both; t test,
mean 6 SD, n = 3).
See also Figure S3.
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Figure 4. Inhibition of Mitochondrial Functions
Increases Cell Size in Cultured Cells
(A) Changes in cell size and cell number in U2OS
cells by small molecules. Compoundswith known
effects on mitochondria are displayed in red.
Glycolysis, glutaminolysis, and PPP compounds
are displayed in blue, and others are displayed
in green. Red and black solid lines display linear
regression for mitochondria targeting and for all
other compounds, respectively, with 90% confi-
dence intervals shown as dotted line. See Table
S5 for all compounds and concentrations used.
(B) U2OS cell number (red line) and cell size (blue
line) were analyzed as a function of Mdivi-1 con-
centration (n = 3, 48 hr).
(C) HeLa cell number (red line) and cell size (blue
line) as a function of phenylbutyrate concentra-
tion in delipidated FBS (n = 3, 48 hr).
(D) Representative cell-size profiles for PGC-1a
knockdown in U2OS and HeLa cells.
(E) Quantification of cell-size changes by two
PGC-1a targeting siRNAs (25 nM) compared to
control RNAi-treated cells (n = 3, 48 hr), with a
western blot showing the knockdown efficiency
in U2OS cells. All treatments except siRNA1 in
U2OS cells had p value < 0.01 (t test).
(F) Rescue of SLC25A1 RNAi (15 nM) by LipidMix
(50 ml/ml) (n = 3, 48 hr). Data shown indicate
mean 6 SD with t test (ns, not significant).
See also Figure S4 and Table S5.
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ylation levels are important for cell proliferation but do not
explain cell size increases.
Becausemitochondrially derived acetyl-CoA is also used for
lipid biosynthesis, we attempted to rescue citrate transporter
SLC25A1 RNAi by supplementing U2OS cells with a commer-
cially available lipid mixture (LipidMix). This almost completely
rescued the cell-size increase caused by SLC25A1 RNAi (Fig-
ure 4F). Interestingly, the effect of Mdivi-1 was also rescued by
addition of LipidMix (Figure S4L).
Repression of Lipid Biosynthesis Increases Cell Size
We considered whether coupling of lipid synthesis and cell
proliferation could explain our observations of mitochondria
and cell size. Gene expression related to de novo lipid biosyn-
thesis negatively correlated with cell size (Figure 5A). Analysis
of individual transcription factors identified the sterol-regula-
tory element binding transcription factor 2 (SREBF2/SREBP2)
as themost negatively correlating (Figure 5B). Analysis of tran-
scription factor families identified E2F, ARID, and ETS factors
correlating positively and STATs and PPARs correlating nega-
tively with cell size (Figure S5A). Interestingly, 17 out of 55
transcription factors with a negative size correlation of <20.3
clustered based on network analysis (Figure S5B), and these
are involved in regulation of lipid metabolism either directly
(SREBPs, PPAR-a, retinoic acid receptors, LXR/Nr1h2,
ChREBP/Mlxipl, and HNF4A) or via inflammatory responses
(STATs and IRFs). The coordinated downregulation of this
network demonstrates the well-known crosstalk between
metabolic and inflammatory signals [23], which is clinically
important in diabetes, obesity, and atherosclerosis.SREBP1 preferentially activates fatty
acid metabolism, whereas SREBP2 acti-
vates cholesterol metabolism [24], and
the activities of SREBP1 and SREBP2are regulated by phosphatidylcholine and cholesterol, respec-
tively [24, 25]. Expression of genes involved in SREBPmatura-
tion was also negatively correlated (Figure S5C). Because
cholesterol synthesis and one-carbon metabolism are SREBP
targets [25], this likely explains their negative correlation of
gene-expression andmetabolite levels with cell size (Figure 2C
and Table S3B).
RNAi of both SREBP1 and SREBP2 increased cell size in
U2OS and hTERT-RPE cells (Figures 5C and S5D). The effect
was dose dependent (Figure S5E), and silencing of SREBP1
and SREBP2 increased cell size more than either treatment
alone (Figure S5F). It has been reported that SREBP RNAi de-
creases the size of RPE cells [26], but this observation may be
due to the combined effects of AKT and hydroxytamoxifen
(note that tamoxifen potently increases cell size) or to more
complete knockdown because SREBP knockout mice are
lethal. Importantly, the SREBP1 and SREBP2 knockdown-
induced cell-size increase in our experiments could be seen
with multiple small interfering RNAs (siRNAs) and could be
rescued with lipid mixture, making it unlikely that this is an
off-target effect (Figures 5C and 5D).
Of all lipid classes, triacylglycerides displayed the best
correlation with cell size (Figure 5E and Table S3C), and this
accumulation of lipids may explain the downregulation of the
lipogenic transcription factors [24, 25]. Although accumulation
of hepatic lipids may lead to fatty liver, Cdk1Liv2/2mice do not
have fatty liver disease based on PPARg expression (Figures
S5G and S5I).
Increased cell size should result in a decrease of the relative
surface area compared to volume. Metabolomics data indi-
cated that the total levels of the detected phospholipids
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Figure 5. SREBP-Mediated Lipid Biosynthesis Is Involved in Modulation of Cell Size
(A) Relative expression of genes in the mevalonate and cholesterol synthesis pathway and fatty acid synthesis pathway decreases with cell size in mouse
liver. The expression values were normalized to the highest expression for each gene.
(B) Histogram of individual transcription factor expression correlation with cell size in mouse liver. Median correlation of all transcription factors (r = 0.275) is
indicated with the dotted line.
(C) Quantification of U2OS cell-size changes by targeting SREBP1 and SREBP2 with nonoverlapping siRNAs (25 nM, n = 3, 60 hr). Knockdown of SREBP2
was validated by western blotting. b-actin was used as loading control. Compared to control, p value < 0.001 with all SREBP siRNAs (t test).
(D) Rescue of cell size by SREBP RNAi using LipidMix in U2OS cells. Significance was analyzed by t test (n = 3, 55 hr).
(E) Correlations (blue bars) and log2 fold changes (red line) for all lipid classes containing more than four metabolites, as classified in LIPID MAPS (http://
www.lipidmaps.org).
(F) Log2 fold changes between smallest and largest liver cells for individual glycerolipids and glycerophospholipids based on the metabolomics measure-
ment. Horizontal line indicates mean (t test).
(G) Measurement of total phospholipids using a colorimetric assay from liver extracts. Phospholipids were normalized to tissue weight. Expected cell-
surface area relative to volume is in red. The differences in phospholipid levels are significant (p < 0.01, ANOVA).
Data shown in (C), (D), and (G) indicate mean 6 SD (n = 3).
See also Figure S5.
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Figure 6. Lipids Modulate Cell Size and Proliferation Ratio
(A) Cell number (red line) and cell size (blue line) were measured after 48 hr (n = 3).
(B) Fatostatin (25 mM) effects on U2OS cell size were rescued by 50 ml/ml LipidMix (n = 3, 64 hr, t test).
(C) U2OS cell number (red line) and cell size (blue line) were analyzed as a function of simvastatin concentration (n = 3, 48 hr).
(D) Simvastatin (7.5 mM) effects on U2OS cell size and cell proliferation were rescued by 5 mM mevalonolactone (n = 3, 60 hr, t test).
(legend continued on next page)
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606(reflecting membrane synthesis) were not changed in larger
cells, whereas storage lipids (triglycerides) were clearly
increased (Figures 5E and 5F). Direct measurement of total
phospholipids in liver samples displayed a minor increase
(Figure 5G). We also reanalyzed a yeast lipidomics experiment
[27] that used haploid and diploid cells. These data revealed
that two of the three most abundant phospholipids are
increased in larger cells. It appears that total phospholipids,
which are present in both plasma membrane and internal
membranes, increase with cell size, and the change in phos-
pholipid levels does not match the change in cell-surface
area (Figure 5G).
To further investigate the relationship between lipids and
cell size, we inhibited SREBP processing using fatostatin.
Fatostatin increased cell size with a reduction in cell
number in multiple cell lines (Figures 6A and S6A). This
effect was almost completely rescued by lipid addition
(Figure 6B). Similar effects were obtained by inhibition of
cholesterol synthesis by simvastatin, which inhibits HMG-
CoA reductase (Figure 6C). Specific rescue of simvastatin
was obtained by mevalonolactone, the end product of the
reaction (Figures 6D and S6B). Opposite effects on cell prolif-
eration and cell size could be seen by supplying HeLa
cells grown in lipid-depleted fetal bovine serum (FBS) with
LipidMix. This treatment dose-dependently increased cell
number and reduced cell size (Figure 6E). This was also
observed to a lesser extent with normal FBS, although higher
concentrations of lipids caused lipotoxicity (Figure S6C). The
lipids were not used as an energy source because inhibition
of beta-oxidation with etomoxir could not rescue this effect
(Figure 6F). Hence, the lipids are either used as building
blocks for membrane or for signaling to the cell-proliferation
machinery.
To further demonstrate that lipids regulate the balance
between cell size and cell proliferation, we increased cell
size by blocking cell-cycle progression using Cdk inhibitor
RO-3306 and DNA synthesis inhibitor gemcitabine (Figures
6G and 6H). Although these treatments significantly in-
creased cell size, cell size could not be rescued by LipidMix.
Thus, cell-cycle arrest and mitochondria-mediated increases
in cell size are distinct, and LipidMix supplementation does
not inhibit cell-size increase but acts by stimulating cell
proliferation.
In diabetic and/or obese patients, excess lipids are associ-
ated with both the decline in mitochondrial functions and
the decline in mitochondrial gene expression [28–30]. We
observed that inhibition of SREBP function with fatostatin
and SREBP RNAi resulted in increased mitochondrial mem-
brane potential (Figures S6D and S6E), indicative of the
well-known feedback mechanism between lipids and mito-
chondrial function. Altogether, our data validate a role formito-
chondria and lipids in regulating the balance between cell size
and cell proliferation.(E) Dose dependence of increased HeLa cell proliferation by LipidMix in delipi
(F) Effect of etomoxir (50 mM) on LipidMix induced HeLa cell proliferation in 10
(G) Effect of LipidMix (50 ml/ml) on cell size in U2OS cells arrested with 7.5 mM
Data shown in (A)–(G) indicate mean 6 SD.
(H) Cell-cycle arrests in G2/M and early S phase by RO-3306 and Gemcitabine
(I) When cells proliferate, highmitochondrial metabolic activity and lipogenic tra
need for plasma membrane lipids decreases. Intracellularly accumulating lipid
lipid synthesis-related gene expression. Downregulated lipid biosynthesis, in tu
are inhibited, proliferation is reduced without directly inhibiting cell growth. SR
See also Figure S6.Discussion
We have investigated how mouse liver cells respond to
increased cell size caused by Cdk1 inactivation and hepa-
tectomy. Whereas cytoskeletal gene expression positively
correlates with cell size, unexpectedly, the expression of mito-
chondrial and de novo lipid biosynthesis genes inversely cor-
relates with cell size. Inhibition of mitochondrial functions
and lipid synthesis increases cell size in culture, suggesting
causality. Although decline in nutrient transport efficiency
and increase in time required for diffusion-limited processes
could potentially limit cell size, Cdk1Liv2/2 cells grow without
signs of energy deprivation. The liver and Drosophila models
indicate that the observed mitochondrial link is not Cdk1
dependent or cell-cycle dependent and that it is a cell-auton-
omous response related to cell size.
A fundamental unresolved issue in cell biology is the
coupling of cell size and cell proliferation. We demonstrate
that the balance between cell size and cell proliferation can
be changed by targeting mitochondria and/or lipid biosyn-
thesis, providing one possible mechanism for this coupling.
Many mitochondrial and lipid metabolism genes are downre-
gulated in proliferating hepatocytes in vivo [31]. However,
because most proliferating cells grow in size before cell divi-
sion, the complete lack of proliferation in our model allows
separation of growth effects. Neutral lipids, such as triglycer-
ides, substantially increase after PH [32], and growth immedi-
ately after hepatectomy occurs by cellular hypertrophy before
initiation of the cell division [33]. This physiological coinci-
dence of growth with lipid accumulation before hepatocyte
proliferation is consistent with our data.
The mitochondrial and glycolytic changes observed in our
model bear similarities to theWarburg effect. Our data suggest
that the Warburg effect is primarily driving cell growth and not
proliferation, as is often thought. Our findings are supported by
a recent study in which the Warburg effect is not needed for
T cell proliferation [34]. Furthermore, increased aerobic glycol-
ysis decouples cell proliferation and biomass production in
yeast [35], and PGC-1a expression correlates with prolifera-
tion of melanoma cells [36]. It is possible that the change in
glycolysis and mitochondrial activity related to cell size may
be more related to optimization of metabolic-precursor pro-
duction than energy production.
At first glance, our results conflict with mTOR effects. mTOR
activity increases cell size and activates lipid biosynthesis,
which increases proliferation and, together with increased
protein biosynthesis, results in increased biomass. In our
experiments, cell size is increased at the cost of reduced pro-
liferation with no increase in biomass production. We also
show that the opposite is true by supplying cells with lipids,
which reduces cell size and increases proliferation. Our results
are consistent with physical laws in which increased cell size is
expected to result in relative reduction of plasma membranedated FBS-containing medium (n = 3, 48 hr).
% lipid-free FBS (n = 3, 60 hr, t test).
RO-3306 or 1 mM Gemcitabine (n = 3, 34 hr).
, respectively, were verified by DNA staining.
nscription-factor levels aremaintained.When cell size increases, the relative
s repress the activity of lipogenic transcription factors and, consequently,
rn, reduces the need formitochondrial metabolism. Similarly, if mitochondria
EBP is shown as an example; SRE is sterol-regulatory element DNA motif.
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607production as volume grows faster than surface area (r3 versus
r2, where r is radius) and generates a scaling problem for a
growing cell. The physical scaling problem assumes that lipids
are used for plasma membrane production and does not take
internal membranes into account. Our analysis suggests that
there is an increase in internal membranes, in membrane
composition, or in free phospholipids because total phospho-
lipid levels are greater in larger cells. On the other hand,
cholesterol is highly plasma membrane enriched, and the
most affected transcription factor was SREBPF2, which is
responsible for cholesterol biosynthesis. To understand the
role of lipids in the scaling problem, we will need to measure
quantities and membrane selectivity of individual lipid species
in detail.
In summary, increased cell size results in the relative reduc-
tion of mitochondrial metabolism and lipid biosynthesis in
mouse liver (Figure 6I). When proliferation is reduced, the
need for plasma membrane components is reduced, and
excess lipids, which are not incorporated into the plasma
membrane, accumulate and inhibit lipogenic transcription fac-
tors. This reduces lipid biosynthesis and, consequently, the
need for mitochondrial metabolism. This negative feedback
thus matches the cell-size and cell-proliferation rate and may
provide a solution for the scaling problem. Thus, lipids, which
are not incorporated into membranes, can potentially be part
of a cell-size-sensing mechanism.
Experimental Procedures
The complete details of the experimental procedures are provided in the
Supplemental Experimental Procedures.
Cdk1 conditional knockout mice have been described previously [15]. All
the procedures performed were in accordance with institutional guidelines
at the Institute of Molecular and Cell Biology, A*STAR, Singapore. Livers
were collected before and 96 hr after partial (70%) hepatectomy. Nuclear
size was calculated from histological sections and normalized to
Cdk1Flox/Flox mice before hepatectomy. Pearson correlation coefficients
were calculated using all samples for each gene and metabolite.
Liver samples were analyzed by RNA sequencing (RNA-seq) and by mass
spectrometry for metabolomics. Cell-size and cell-number measurements
were conducted using flow cytometry. Small molecules were from Sigma-
Aldrich, Tocris, Santa-Cruz, or Calbiochem. RNAi was performed by
transfecting siRNAwith HiPerfect (QIAGEN). The siRNA and oligonucleotide
sequences are in Table S6. Antibodies were detected using infrared-dye
conjugated secondary antibodies and LICOR Odyssey detection system.
For electron microscopy, liver pieces were fixed and exposed to osmium
tetroxide and then embedded in Spurr’s resin.
Accession Numbers
The ArrayExpress Archive accession number for the liver gene-expression
data in this paper is E-MTAB-1297.
Supplemental Information
Supplemental Information includes Supplemental Experimental Proce-
dures, six figures, and six tables and can be found with this article online
at http://dx.doi.org/10.1016/j.cub.2014.01.071.
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